| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |